ライフサイエンスコーパス: transforming growth factor

1 While the molecular pathways by which transforming growth factor-1 (TGF-beta1) activates pro-f

2 tocrine/paracrine release of the EGFR ligand transforming growth factor alpha in a TACE-dependent man

3 e, RHBDL4 enables the release of full-length transforming growth factor alpha in exosomes.

4 erase (GLuc), epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha) and epiregu

5 bed chimeric Galpha subunit activation via a transforming growth factor-alpha (TGF-alpha) shedding re

6 0 (CXCL10), interleukin-2 (IL-2), IL-1alpha, transforming growth factor-alpha (TGF-alpha).

7 ach to characterize the robustness of gurken/transforming growth factor-alpha mRNA localization in Dr

8 al interactions of the Notch ligand DLL4 and transforming growth factor-b (TGF-beta) family ligands p

9 athways govern epithelial proliferation, and transforming growth factor beta (TGF-beta and BMP signal

10 Our observations suggest that transforming growth factor beta (TGF-beta) and peroxisom

11 This in turn leads to the expression of transforming growth factor beta (TGF-beta) and widesprea

12 that during immune homeostasis, the cytokine transforming growth factor beta (TGF-beta) epigeneticall

13 Chlamydia also upregulates transforming growth factor beta (TGF-beta) expression, w

14 and GDF11 are closely related members of the transforming growth factor beta (TGF-beta) family.

15 phiregulin functioned by releasing bioactive transforming growth factor beta (TGF-beta) from latent c

16 d reduced the levels of interferon gamma and transforming growth factor beta (TGF-beta) in mice with

17 Transforming growth factor beta (TGF-beta) is a potent i

18 Human milk (HM) transforming growth factor beta (TGF-beta) is critical f

19 earch suggests that profibrotic signaling by transforming growth factor beta (TGF-beta) is directly t

20 The cytokine transforming growth factor beta (TGF-beta) is induced on

21 Transforming growth factor beta (TGF-beta) is well known

22 Dysregulated signaling in the transforming growth factor beta (TGF-beta) pathway plays

23 This platform nominated a novel transforming growth factor beta (TGF-beta) R2-41BB chime

24 in (BMP) Receptor-1A as OAC but only 1/12 of Transforming Growth Factor beta (TGF-beta) Receptor-1.

25 to myofibroblasts through hyperactivation of transforming growth factor beta (TGF-beta) signaling in

26 clerosis, hypercholesterolemia, and abnormal transforming growth factor beta (TGF-beta) signaling in

27 Here, we report that, in the absence of Transforming Growth Factor beta (TGF-beta) signaling in

28 The interplay between the transforming growth factor beta (TGF-beta) signaling pro

29 lin-like (insulin/IGF-1 signaling [IIS]) and transforming growth factor beta (TGF-beta) signaling rep

30 d medullary keratinocytes, guided by Bmp and transforming growth factor beta (TGF-beta) signaling tha

31 rominent function of TGIF1 is suppression of transforming growth factor beta (TGF-beta) signaling, wh

32 lial homing alpha-E integrin (CD103) through transforming growth factor beta (TGF-beta) signaling.

33 Transforming growth factor beta (TGF-beta) signals throu

34 epsilonRIalpha(+) macrophages send paracrine transforming growth factor beta (TGF-beta) signals to TI

35 ts indicate that CREB acts downstream of the transforming growth factor beta (TGF-beta) Sma/Mab pathw

36 virions binds the immunosuppressive cytokine transforming growth factor beta (TGF-beta) through a lig

37 d important cellular pathways like STAT1 and transforming growth factor beta (TGF-beta) to be differe

38 of the cytokines interleukin (IL)-6, IL-10, transforming growth factor beta (TGF-beta), and interfer

39 y modulating fibroblast growth factor (FGF), transforming growth factor beta (TGF-beta), and WNT path

40 the prototypical prosclerotic growth factor, transforming growth factor beta (TGF-beta), is thought t

41 d by inducible nitric oxide synthase (iNOS), transforming growth factor beta (TGF-beta), NADPH oxidas

42 Transforming growth factor beta (TGF-beta), which acted

43 Transforming growth factor beta (TGF-beta), which induce

44 ic regulation of lipid metabolism, involving transforming growth factor beta (TGF-beta)-regulated pho

45 (RNA-seq) and lineage tracing, we found that transforming growth factor beta (TGF-beta)-responding tS

46 ss isoforms of the antiinflammatory cytokine transforming growth factor beta (TGF-beta).

47 sition of a mesenchymal phenotype induced by transforming growth factor beta (TGF-beta).

48 d by various pathological stimuli, including transforming growth factor beta (TGF-beta).

49 chondrogenic differentiation by influencing transforming growth factor beta (TGF-beta)/SMAD family 2

50 ollagen remains poorly understood apart from Transforming Growth Factor beta (TGF-beta1)-mediated ind

51 for fibrillin-1 in regulating extracellular transforming growth factor beta (TGFB) bioavailability a

52 M) family, which interact with microbes, and transforming growth factor beta (TGFB) signaling pathway

53 and was found to activate complex of latent transforming growth factor beta (TGFbeta at the surface

54 Here, we found transforming growth factor beta (TGFbeta) and bone morph

55 We use stepwise modulation of the transforming growth factor beta (TGFbeta) and fibroblast

56 Transforming Growth Factor Beta (TGFbeta) and insulin-li

57 trogen-mediated uterine functions, including transforming growth factor beta (TGFbeta) and LIF interl

58 Transforming growth factor beta (TGFbeta) can protect ag

59 The transforming growth factor beta (TGFbeta) family is a hi

60 Transforming growth factor beta (TGFbeta) is a multipote

61 eterozygous, loss-of-function mutations in 4 transforming growth factor beta (TGFbeta) pathway member

62 prostate stem or progenitor activity via the transforming growth factor beta (TGFbeta) pathway.

63 Transforming growth factor beta (TGFbeta) potently activ

64 identified progesterone receptor action and transforming growth factor beta (TGFbeta) signaling via

65 The transforming growth factor beta (TGFbeta) signalling pat

66 The transforming growth factor beta (TGFbeta) superfamily in

67 (BMPs) are multifunctional cytokines of the transforming growth factor beta (TGFbeta) superfamily wi

68 were treated with the pro-scarring cytokine, transforming growth factor beta (TGFbeta) to induce coll

69 Transforming growth factor beta (TGFbeta) upregulates ch

70 Instead, the transcription factor Twist1, transforming growth factor beta (TGFbeta), and YAP activ

71 in (IL6) beta2SP(+/-) LSCs was activated by transforming growth factor beta (TGFbeta)-activated kina

72 modular glycoprotein that includes 7 latent transforming growth factor beta (TGFbeta)-binding protei

73 ates with SMAD3 to modulate transcription of transforming growth factor beta (TGFbeta)-dependent gene

74 ) and lipoma-preferred partner (LPP) mediate transforming growth factor beta (TGFbeta)-induced breast

75 ion are consistent with dysregulation of the transforming growth factor beta (TGFbeta)/bone morphogen

76 ood allergy (FA) had decreased expression of transforming growth factor beta 1 (TGF-beta1) because of

77 eloid cells, which reduced the production of transforming growth factor beta 1 (TGF-beta1), a cytokin

78 Fibrosis was induced in PCLSs by transforming growth factor beta 1 (TGFbeta1) and platele

79 okines produced by T-helper type 2 cells and transforming growth factor beta 1 (TGFbeta1) contribute

80 e subclass expressed many genes regulated by transforming growth factor beta 1 that mediate immunosup

81 the likely effector genes, including TGFB1 (transforming growth factor beta 1), FGF18 (fibroblast gr

82 ystatin B, the latency-associated peptide of transforming growth factor beta 1, oxidized low-density

83 r 1 (HIF-1), monocyte chemotactic protein 1, transforming growth factor beta 1, TIR-domain containing

84 Transforming growth factor beta 1-driven fibroblast-to-m

85 XA1 loss leads to remarkable upregulation of transforming growth factor beta 3 (TGFB3), which encodes

86 yte-macrophage colony-stimulating factor and transforming growth factor beta alone, whereas CD14(+) c

87 ificantly higher profibrotic pathway levels (transforming growth factor beta and collagen-1) than in

88 -inflammatory upstream regulators, including transforming growth factor beta and interleukin 10 recep

89 Transforming growth factor beta increased miR-144-3p exp

90 mouse embryonic fibroblasts and T cells with transforming growth factor beta increased their producti

91 The transforming growth factor beta inhibitor Smad7 determin

92 ed NTHi infection up to 3 days increased the transforming growth factor beta levels, decreasing the e

93 ugh the SMAD2 transcription modulator of the transforming growth factor beta pathway, which activates

94 with or without RSPO1-Fc and an inhibitor of transforming growth factor beta receptor (TGFBR).

95 regulated expression of alphaSMA, PDGFbetaR, transforming growth factor beta receptor 1 (TGFbetaR1),

96 we characterize the biologic effects of two transforming growth factor beta receptor 1 (TGFBR1) kina

97 es in this study suggests that activation of transforming growth factor beta signaling and epithelial

98 anisms of pathogenesis centered on disrupted transforming growth factor beta signaling and hippocampa

99 The sCYLD-SMAD7 complex inhibited transforming growth factor beta signaling in CD4(+) T ce

100 translocation of SMAD7 and thereby decreases transforming growth factor beta signaling in T cells.

101 biopsies from MS patients revealed decreased transforming growth factor beta signaling with a shift t

102 esion, epithelial-to-mesenchymal transition, transforming growth factor beta signaling, maintenance o

103 al signaling pathways and a united defect in transforming growth factor beta signaling.

104 ppress the immune response and activation of transforming growth factor beta signaling; or expression

105 ept, a recombinant fusion protein that binds transforming growth factor beta superfamily ligands to r

106 ombinant fusion protein that binds to select transforming growth factor beta superfamily ligands, may

107 ntiation factor 8 (GDF8)) is a member of the transforming growth factor beta superfamily of growth fa

108 rity to other closely related members of the transforming growth factor beta superfamily.

109 lowing isotropic chondrogenic induction with transforming growth factor beta to set up a dual-compart

110 nal pathways of activation, such as TGFbeta (transforming growth factor beta) and AngII (angiotensin

111 cues with the profibrotic agonist, TGFbeta (transforming growth factor beta), additively upregulated

112 erived growth factor BB, and unresponsive to transforming growth factor beta, a prominent cytokine of

113 actor kappa B, interleukin-6, interleukin-8, transforming growth factor beta, and vascular endothelia

114 h as proliferation-progenitor, proliferation-transforming growth factor beta, and Wnt-catenin beta1.

115 ctin, and the latency-associated peptides of transforming growth factor beta, in a MIDAS/cation-indep

116 g of concurrent reduced quantities of active transforming growth factor beta, while mucosal IgM is si

117 protein that uniquely associates with latent transforming growth factor beta-1 (TGF- beta1) and ancho

118 Transforming growth factor beta-1 (TGFbeta1) is a major

119 Transforming growth factor beta-1 (TGFbeta1) is a major

120 Mechanistically, transforming growth factor beta-1 (TGFbeta1)-producing m

121 Transforming growth factor beta-1 signaling and SMAD3 ac

122 critical elements of fibrogenesis, including transforming growth factor beta-1-SMAD3 activation, prod

123 (BA) abnormalities, we find that microglial transforming growth factor beta-activated kinase 1 (Tak1

124 ted kinase-1 (IRAK-1) and IRAK-4, as well as transforming growth factor beta-activated kinase 1 (TAK1

125 ng disorders such as Alzheimer's disease and transforming growth factor beta-induced protein (TGFBIp)

126 an CFC tissue, but surprisingly, more active transforming growth factor beta.

127 2(-/-) HSCs, defects were identified in each transforming growth factor beta/Smad2/3 and ET-1/Erk1/2

128 his leads to increased T(REG) sensitivity to transforming growth factor - beta and promotes transplan

129 grin protein expression and upregulated TGF (transforming growth factor)-beta and CTGF (connective ti

130 Members of the TGF (transforming growth factor)-beta family are upregulated

131 TGF (transforming growth factor)-beta is critically involved

132 tg16l1 deficient CD11b(+) DCs develop a TGF (transforming growth factor)-beta-dependent tolerogenic p

133 8 binds with exquisite specificity to latent transforming growth factor-beta (L-TGF-beta).

134 AD2 and SMAD3 are downstream proteins in the transforming growth factor-beta (TGF beta) signaling pat

135 Myostatin (MSTN) is a transforming growth factor-beta (TGF-beta) family member

136 Encoded in mammalian cells by 33 genes, the transforming growth factor-beta (TGF-beta) family of sec

137 proteins (BMPs) are secreted ligands of the transforming growth factor-beta (TGF-beta) family that c

138 17 (Th17) cell differentiation by activating transforming growth factor-beta (TGF-beta) from its late

139 Functions of transforming growth factor-beta (TGF-beta) in the liver

140 uppressive function through increased active transforming growth factor-beta (TGF-beta) in Tregs sign

141 Transforming growth factor-beta (TGF-beta) is major indu

142 Transforming growth factor-beta (TGF-beta) is produced b

143 Transforming growth factor-beta (TGF-beta) is well-known

144 f the TGF-beta family that selectively binds transforming growth factor-beta (TGF-beta) isoforms and

145 ovine tendons, which is capable of enhancing transforming growth factor-beta (TGF-beta) mediated teno

146 In particular, we show that the transforming growth factor-beta (TGF-beta) pathway and t

147 ction mutations in positive effectors of the transforming growth factor-beta (TGF-beta) pathway.

148 ey also increased interleukin-10 (IL-10) and transforming growth factor-beta (TGF-beta) production an

149 Transforming growth factor-beta (TGF-beta) promotes tumo

150 Functional activation of the transforming growth factor-beta (TGF-beta) receptors (TG

151 Because transforming growth factor-beta (TGF-beta) signaling is

152 Smad7, a general antagonist against transforming growth factor-beta (TGF-beta) signaling, is

153 of ILC1-like cells concurrent with increased transforming growth factor-beta (TGF-beta) signaling.

154 blasts requires both a mechanical signal and transforming growth factor-beta (TGF-beta) signaling.

155 Oxidative stress or transforming growth factor-beta (TGF-beta) stimulated EM

156 Transforming growth factor-beta (TGF-beta) superfamily m

157 Here we found that transforming growth factor-beta (TGF-beta) superfamily m

158 ntiation factor-15 (GDF-15), a ligand in the transforming growth factor-beta (TGF-beta) superfamily,

159 this study, we investigated the role of the transforming growth factor-beta (TGF-beta) superfamily,

160 Here, following the finding that transforming growth factor-beta (TGF-beta) suppresses T

161 e cutaneous SSc (dcSSc); (ii) the ability of Transforming Growth Factor-beta (TGF-beta) to modulate E

162 erleukin-1 receptor antagonist (IL-1RA), and transforming growth factor-beta (TGF-beta)) with inciden

163 In response to transforming growth factor-beta (TGF-beta), epithelial a

164 has been implicated in airway diseases where transforming growth factor-beta (TGF-beta)-induced epith

165 is implicated in the profibrotic actions of transforming growth factor-beta (TGF-beta).

166 plastic BE tissues showed hyperactivation of transforming growth factor-beta (TGFB) and/or Jun N-term

167 inflammatory cues including interferons and transforming growth factor-beta (TGFbeta) cytokines.

168 Endoglin (ENG) is a coreceptor of the transforming growth factor-beta (TGFbeta) family signali

169 Transforming growth factor-beta (TGFbeta) is a potent in

170 Transforming growth factor-beta (TGFbeta) is an enigmati

171 wing antigen-driven expansion in lymph node, transforming growth factor-beta (TGFbeta) is required fo

172 mpathetic nervous systems, activation of the transforming growth factor-beta (TGFbeta) pathway, abnor

173 levels of Smad7, a negative regulator of the transforming growth factor-beta (TGFbeta) pathway.

174 proteins upon stimulation of fibroblasts by transforming growth factor-beta (TGFbeta) play a critica

175 In Peyer's patches (PPs), transforming growth factor-beta (TGFbeta) promotes IgA i

176 static regulation by multiple ligands of the transforming growth factor-beta (TGFbeta) superfamily.

177 Transcriptional targets of transforming growth factor-beta (TGFbeta) were dysregula

178 tegrin plays a key role in the activation of transforming growth factor-beta (TGFbeta), a pro-fibroti

179 shared fibrotic signalling responses such as transforming growth factor-beta (TGFbeta), platelet-deri

180 iated with upregulation of genes involved in transforming growth factor-beta (TGFbeta), reactive oxyg

181 Such pathways include transforming growth factor-beta (Tgfbeta), sonic hedgeho

182 , and metastasis abilities of ESCC cells via transforming growth factor-beta (TGFbeta)-dependent Dros

183 Interaction of transforming growth factor-beta (TGFbeta)-induced canoni

184 ins in response to an external signal, often transforming growth factor-beta (TGFbeta).

185 receptor, WNT, receptor tyrosine kinase and transforming growth factor-beta (TGFbeta)/bone morphogen

186 tractant protein-1 (MCP-1) (0.798, p<0.005), transforming growth factor-beta 1 (1.009, p<0.05), solub

187 ophage colony-stimulating factor (M-CSF) and transforming growth factor-beta 1 (TGF-beta1) in the pre

188 report did not contrast KGN directly against transforming growth factor-beta 1 (TGF-beta1), the most

189 Exaggerated transforming growth factor-beta 1 (TGFbeta1) expression

190 ns of different epitheliotropic factors (eg, transforming growth factor-beta [TGF-beta1], epidermal g

191 erleukin-1 receptor antagonist [IL-1RA], and transforming growth factor-beta [TGF-beta]), with incide

192 nockdown of PCSK6 in cardiomyocytes impacted transforming growth factor-beta activation and SMAD3 (mo

193 decapentaplegic homolog 2/SMAD2, suggesting transforming growth factor-beta activation.

194 Stromal factors such as transforming growth factor-beta and fibroblast activatio

195 developments concerning the roles played by transforming growth factor-beta and platelet-derived gro

196 s in development - such as the activation of transforming growth factor-beta and the deposition of ex

197 ein previously shown to interact with latent transforming growth factor-beta binding protein 1 and in

198 rs, angiopoietin-2, thrombospondin-2, latent transforming growth factor-beta binding protein-4, and f

199 We also report a role for transforming growth factor-beta in promoting the convers

200 naling in epithelial-mesenchymal transition, transforming growth factor-beta interacted with Panx3 by

201 Transforming growth factor-beta maintains DPP4+ cell ide

202 Transforming growth factor-beta membrane associated prot

203 of the mitogen-activated protein kinase and transforming growth factor-beta pathways in Exoc5 knockd

204 ency-associated protein associated with Treg transforming growth factor-beta production and presentat

205 3(+) regulatory T cells (Tregs) and enhanced transforming growth factor-beta production by CD4(+) T c

206 Here we show that depletion of transforming growth factor-beta receptor 2 (TGFBR2) in C

207 [FGF21], alphaKlotho, soluble form of mouse transforming growth factor-beta receptor 2 [sTGFbetaR2])

208 Here we examine the effect of EGF on transforming growth factor-beta receptor II (TGF-betaRII

209 n beta8 associated with Treg and CD103(+) DC transforming growth factor-beta release.

210 ondrial function and autophagy and decreased transforming growth factor-beta signaling and activity o

211 Noncanonical transforming growth factor-beta signaling and different

212 cant down-regulation of connective tissue or transforming growth factor-beta signaling genes.

213 of additional pathways, such as induction of transforming growth factor-beta signaling in BRAF melano

214 cell cycle, angiogenesis, inflammation, and transforming growth factor-beta signaling in tumor blood

215 sregulation of ephrin-receptor signaling and transforming growth factor-beta signaling pathways.

216 ppo-Yes-associated protein (YAP) pathway and transforming growth factor-beta signalling.

217 The transforming growth factor-beta superfamily, including a

218 on of BMPR2, which encodes a receptor in the transforming growth factor-beta superfamily, the develop

219 Ps) are secreted proteins that belong to the transforming growth factor-beta superfamily.

220 Here, we showed that transforming growth factor-beta(1) (TGF-beta(1)), the ke

221 Transforming growth factor-beta(1) and vascular endothel

222 Immunofluorescence for transforming growth factor-beta(1), vascular endothelial

223 molecular markers of fibrosis (collagen and transforming growth factor-beta) and immunostaining for

224 TGF-beta (transforming growth factor-beta) is the main profibrotic

225 kappaB (nuclear factor kappaB), and TGFbeta (transforming growth factor-beta) pathways, which were va

226 TGFbeta (transforming growth factor-beta) signaling mutations hav

227 t BRD4 functions as an effector of TGF-beta (transforming growth factor-beta) signaling to stimulate

228 eukin-12 [IL-12], IL-23, IL-6, IL-27, IL-10, transforming growth factor-beta) that expand and differe

229 in cardiac fibroblasts as well as TGF-beta (transforming growth factor-beta)-activated myofibroblast

230 TP-10 also reduced TGF-beta (transforming growth factor-beta)-stimulated cardiac fibr

231 enitor capacity, and activation of TGF-beta (transforming growth factor-beta)/SMAD signaling.

232 reased, whereas tumor necrosis factor-alpha, transforming growth factor-beta, and fibrosis were remar

233 Transforming growth factor-beta-1 (TGFbeta1) increased g

234 also decreased the expression of TGF-beta1 (transforming growth factor-beta-1) and CTGF (connective

235 cytokines by interacting with and inhibiting transforming growth factor-beta-activated kinase 1 (TAK1

236 ed protein kinase (MAPK) via a non-canonical transforming growth factor-beta-activated protein kinase

237 ermeability was preceded by an activation of transforming growth factor-beta-activating kinase-1 (TAK

238 Mutations in transforming growth factor-beta-induced (TGFBI) gene cau

239 o induce Cox-2 in fibroblasts and to inhibit transforming growth factor-beta-induced alpha-SMA expres

240 Mechanistically, sphingosine ameliorates transforming growth factor-beta-induced collagen accumul

241 determined EMT in the presence or absence of transforming growth factor-beta.

242 including interleukin 10 (IL-10), IL-35 and transforming growth factor-beta.

243 de was further designed for the detection of transforming growth factor beta1 (TGF-beta1) protein in

244 riggered by tumour cell-derived factors like transforming growth factor beta1 (TGF-beta1), myofibrobl

245 Disrupting megakaryocytic transforming growth factor beta1 (Tgfb1) disorganized he

246 Transforming growth factor beta1 (TGFbeta1) has been sho

247 Transforming growth factor beta1 (TGFbeta1) is a cytokin

248 HDAC8 siRNA was also effective in inhibiting transforming growth factor beta1 (TGFbeta1)-induced deac

249 0, and CD86) and anti-inflammatory cytokine (transforming growth factor beta1 [TGF-beta1]) were suppr

250 e reveal widespread translational effects of transforming growth factor beta1 and define novel posttr

251 al cellular reactions including secretion of Transforming Growth Factor beta1 ubiquitously in a laten

252 TGF-beta1 (transforming growth factor beta1), downstream of neutrop

253 rganization, or being connected to TGFbeta1 (transforming growth factor beta1), interleukin-1, TNF-al

254 otide-resolution translatome data during the transforming growth factor beta1-driven cellular transit

255 rd profibrotic myofibroblasts in response to transforming growth factor beta1.

256 inical benefits of global inhibition of TGF (transforming growth factor)-beta1 signaling remain contr

257 Six cardiac-specific TGF (transforming growth factor)-beta1 transgenic and 6 wild-

258 /-) (alias Abcb4(-/-)) mice through enhanced transforming growth factor-beta1 (TGF-beta1) biliary sec

259 Transforming growth factor-beta1 (TGF-beta1) expression

260 lation of mRNA expressions of Collagen I and transforming growth factor-beta1 (TGF-beta1) following t

261 Transforming growth factor-beta1 (TGF-beta1) is elevated

262 Transforming growth factor-beta1 (TGF-beta1) plays a pre

263 vated protein kinase (ERK1/2 MAPK)-dependent transforming growth factor-beta1 (TGF-beta1) signaling t

264 Active transforming growth factor-beta1 (TGF-beta1), a cytokine

265 PLOD2 expression is induced by hypoxia and transforming growth factor-beta1 (TGF-beta1), well-known

266 ar (fibrillar) fibronectin on the surface of transforming growth factor-beta1 (TGF-beta1)-activated h

267 s of the Large Latent Complex that restrains transforming growth factor-beta1 (TGF-beta1).

268 formation is tied to signaling downstream of transforming growth factor-beta1 (TGF-beta1).

269 ent also reduces migration and deposition of transforming growth factor-beta1 (TGFbeta1)-stimulated c

270 cells, M2 macrophages, and markedly elevated transforming growth factor-beta1 and IL-6 levels, which

271 s well as by inflammatory cytokines, whereas transforming growth factor-beta1 caused decreased expres

272 , exogenous apoptotic cells failed to induce transforming growth factor-beta1 expression or Treg accu

273 In activation of the transforming growth factor-beta1 precursor (pro-TGF-beta

274 Gene set enrichment analysis uncovered transforming growth factor-beta1 signaling activation in

275 sion and epigenetic changes with and without transforming growth factor-beta1 treatment, even after c

276 is strongly associated with up-regulation of transforming growth factor-beta1.

277 ating insulin resistance, in particular, the transforming growth factor-beta1/SMAD 2/3 pathway and it

278 [erbb-b2 receptor tyrosine kinase 2], TGFB1 [transforming growth factor-beta1], AREG [amphiregulin],

279 teinase 1, platelet-derived growth factor c, transforming growth factor beta2) and inflammation (tumo

280 46), placental growth factor (P = .027), and transforming growth factor-beta2 (P = .017).

281 e, we show that, in the absence of exogenous transforming growth factor-beta2 (TGFbeta2), compared wi

282 encodes a key biliary-specific subunit of a transforming growth factor (TGF) beta activator (P = 0.0

283 ert a gain-of-function mechanism, augmenting transforming growth factor (TGF) beta signaling.

284 cluding bone morphogenetic protein (BMP) and transforming growth factor (TGF) beta signaling.

285 from rabbit corneal fibroblasts treated with transforming growth factor (TGF) beta-1 or generated dir

286 4 and CRIS-B), and drives metastasis through transforming growth factor (TGF) beta-dependent neutroph

287 binding directly to DNA or interacting with transforming growth factor (TGF) beta-responsive SMADs.

288 y arteriovenous malformations (AVM), through transforming growth factor (TGF)-beta and angiopoietin-2

289 thasone enhanced the pro-fibrotic effects of transforming growth factor (TGF)-beta as a potential mec

290 These disorders are regulated mainly through transforming growth factor (TGF)-beta family proteins by

291 Transforming growth factor (TGF)-beta is a crucial enfor

292 induce bladder fibrosis via induction of the transforming growth factor (TGF)-beta level.

293 Transforming growth factor (TGF)-beta suppresses early h

294 n alphavbeta8 has a major role in activating transforming growth factor (TGF)-beta, a potent inhibito

295 nf)4alpha, Yes-associated protein (Yap), and transforming growth factor (Tgf)-beta.

296 first documented protein known to stimulate transforming growth factor (TGF)-beta1 to -beta3 transla

297 c) mice, Smad7 transgene expression reversed transforming growth factor (TGF)-beta1 transgene-induced

298 Tissue levels of transforming growth factor (TGF)-beta1, lysyl oxidase, p

299 effect of neratinib on HSC was evaluated in transforming growth factor (TGF-beta)-incubated LX-2 cel

300 Transforming growth factor (TGFbeta) is a secreted facto